MedPath

Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19

Completed
Conditions
Vertical Transmission of Infectious Disease
Covid19
Pregnancy Related
Neonatal Infection
Interventions
Diagnostic Test: Reviewed clinical records and laboratory results
Registration Number
NCT04883801
Lead Sponsor
Kahramanmaras Sutcu Imam University
Brief Summary

A case-control trial was conducted to test the early postpartum period clinical outcomes of newborns born to pregnant women with and without COVID-19.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
202
Inclusion Criteria

Pregnant women on labor or preterm labor. Pregnant women who underwent programmed or emergence cesarean

Exclusion Criteria

Those who were transferred to another hospital without or within a short period of delivery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control groupReviewed clinical records and laboratory resultsNewborns born to pregnant women who were not diagnosed with COVID-19 in their medical history and hospitalization for delivery
COVID-19 case groupReviewed clinical records and laboratory resultsNewborns born to pregnant women diagnosed with COVID-19 during hospitalization for delivery
Primary Outcome Measures
NameTimeMethod
Vertical transmission48 hours after birth

Determine the prevalence of COVID-19 in newborns born to pregnant women with COVID-19 with PCR from a nasopharyngeal swab.

Neonatal birth outcomesAt birth

Determine the neonatal outcomes of the newborn specifying the birth week of the newborn, delivery type (vaginal or cesarean), birth weight (g), APGAR scores in the first and fifth minutes after birth.

Neonatal postnatal outcomesWithin 48 hours after birth

Determine the prevalence of neonatal postnatal outcomes of the newborn specifying the respiratory system illness, intensive care need, oxygen need, neonatal mortality, general health status, and breastfeeding status.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Denizli State Hospital

🇹🇷

Denizli, Turkey

© Copyright 2025. All Rights Reserved by MedPath